Even though almost all U.S.-based cannabis organizations and several foreign American Depository Receipts (ADRs) trade within the countertop (OTC), several cannabis businesses are traded in the NASDAQ. Some investors choose stocks which are listed on the NASDAQ to other exchanges because of the increased liquidity and tighter spreads compared to the over-the-counter areas. For instance, since the cannabis industry is continuing to grow in present months and years, uplisting from an OTC market to a professional U.S. trade is now an advertising achievement for a lot of increasing marijuana organizations. (For related reading, see „Understanding healthcare Cannabis vs. Recreational Cannabis shares”)
An increasing wide range of cannabis businesses are now being noted on reputable U.S. exchanges instead of being exchanged regarding the OTC market showing the rapid development of the cannabis industry.
NASDAQ-listed Marijuana Stocks
The NASDAQ was the very first electronic change and is certainly synonymous with technology and biotechnology. The cannabis companies in the NASDAQ mirror this, and also the most of them run into the biotech area of this industry. Here you will find the NASDAQ-listed cannabis shares, in alphabetical purchase, at the time of October 26, 2019, with a failure of the total returns.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals is just a biotech business active in the production of medical cannabis medications. Research and development around Arena’s APD371 may be the focus that is primary of company’s cannabis biotech initiatives.
Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)
Atlantic Alliance Partnership Corp. is a check this is certainly blank that is currently in a merger contract with Kalyx developing Inc. Kalyx is a respected owning a home trust in the regulated cannabis industry in the usa.
- The cannabis industry, specially the part of cannabis and what is cbd biotech, is attracting significant investor attention.
- Cannabis will be utilized in brand new drugs to treat discomfort and chronic that is many inflammatory, and fibrotic conditions.
- Businesses may also be developing cannabinoid services and products for autism range problems, schizophrenia, glioma, Tourette problem, epileptic problems, Prader-Willi Syndrome (an inherited condition), and amphetamine addiction.
Cara Therapeutics Inc. (NASDAQ:CARA)
Cara Therapeutics is just a clinical-stage biotechnology business focused on developing and commercializing chemical that is new for the indications of discomfort and pruritus (itching). Although all the company’s clinical-stage items target opioid receptors, Cara happens to be performing research that is preclinical cannabinoids to treat neuropathic pain.
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)
Corbus Pharmaceuticals Holdings Inc. is a cannabis biotech business. The team’s research, development, and production are based around cannabis medications that look for to treat chronic, inflammatory, fibrotic, as well as other conditions.
Cronos Group Inc. (NASDAQ:CRON)
Cronos Group Inc. is really A canadian cannabis company. The team has and seeks cannabis-related subsidiaries and licensed manufacturers. In December of 2018, Marlboro manufacturer Altria announced plans to spend $1.8 billion in Cronos. The investment has provided Cronos not just with extra money to fund its continued expansion but additionally with a well-established partner experienced within the marketing of customer brands.
Greenlane Holdings Inc. (NASDAQ:GNLN)
Greenlane Holdings Inc. is really a Boca Raton, Florida-based cannabis company. It distributes many different cannabis usage add-ons and vaporization equipment and items to customers that are retail the U.S. and Canada. Also, it runs e-commerce sites for additional product sales.
GW Pharmaceuticals Plc. (NASDAQ:GWPH)
GW Pharmaceuticals is creating a profile of cannabinoid medicines. These medications consist of Sativex to treat spasticity associated with sclerosis that is multiple cancer tumors discomfort and Epidiolex for the treating childhood epilepsy. Sativex is commercialized much more than the usual dozen nations outside of the United States and has now gotten regulatory approval in various other countries. Epidiolex received Food And Drug Administration approval as a treatment for Dravet Syndrome and Lennox-Gastaut Syndrome, two kinds of serious, very early onset epilepsy without good existing treatment plans. Other indications show that GW Pharmaceuticals is developing products that are cannabinoid autism range problems, schizophrenia, and glioma.
Intec Pharma Ltd. (NASDAQ:NTEC)
Intec Pharma is a clinical-stage biopharmaceutical business that is developing medications according to its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based medications for lower back pain and fibromyalgia.
Marrone Bio Innovations, Inc. (NASDAQ:MBII)
Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based management that is pest plant wellness services and products. In 2017, Marrone Bio Innovations announced that three MBII active ingredients are now legal to be used on cannabis plants into the California cultivation market.
Modern Beverages Corp. (NASDAQ:NBEV)
Modern age Beverages Corp. is just a maker of beverages produced from yerba mate, green tea extract, kombucha, and comparable services and products. In recent months, modern age has expanded its beverage offerings to add CBD infusions too, bringing it to the orbit of cannabis shares.
OrganiGram Holdings Inc. (NASDAQ:OGI)
Canadian cannabis producer OrganiGram Holdings Inc. debuted from the NASDAQ in might of 2019, rendering it perhaps one of the most current cannabis businesses to record from the popular change. The organization was rapidly expanding its production capability that can manage to create just as much as 113,000 kilograms of item per year by the end of 2019.
Psychemedics Corporation (NASDAQ:PMD)
Psychemedics Corporation operates when you look at the enforcement sector. The company’s business operations support medication screening through hair samples.
Sundial Growers Inc. (NASDAQ:SNDL)
Alberta, Canada-based Sundial Growers Inc. is yet another brand new entry on the NASDAQ exchange. The cannabis producer made headlines in October of 2019 (and saw a short cost boost) whenever it announced the production of a fresh Palmetto model of recreational cannabis, first for sale in Saskatchewan and Manitoba.
Therapix Biosciences Ltd. (NASDAQ:TRPX)
Therapix Biosciences Ltd. is a specialty clinical-stage company that is pharmaceutical regarding the growth of cannabinoid-based medications. Therapix’s present pipeline includes services and products targeted to treat Tourette problem and mild intellectual disability.
Tilray Inc. (NASDAQ:TLRY)
Tilray Inc. ended up being 1st company that is marijuana-related have a preliminary public providing (IPO) in the us. The Nanaimo, Vancouver Island-based company concentrates on medical cannabis services and products.
Village Farms International (NASDAQ:VFF)
Village Farms Global is the most present cannabis stock to begin dealing from the NASDAQ. The business’s stocks became readily available for trade on February 21, 2019. The organization has a history that is decades-long greenhouse produce manufacturing and contains just recently shifted a number of its focus toward cannabis manufacturing.
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)
Zynerba Pharmaceuticals is targeted in the growth of synthetic treatments that are cannabinoid transdermal (through your skin) delivery. Their pipeline currently includes two medications being developed for indications including epilepsy, osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.